Massive study reveals eye inflammation rates in common treatment
NCT ID NCT07105228
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study looked at nearly 290,000 people in the US who received aflibercept eye injections to treat various retinal diseases. The goal was to find out how often retinal vasculitis (a type of eye inflammation) occurs after these injections. Researchers used a large insurance database to track cases and describe patient characteristics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL VASCULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regeneron Research Site
Tarrytown, New York, 10591, United States
Conditions
Explore the condition pages connected to this study.